C

Charlotte Gastroenterology and Hepatology | Randolph Road Office

Research site

(Unclaimed)

Location

2015 Randolph Road Suite 208, Charlotte, North Carolina, United States of America

Site insights

Top conditions

Top treatments

ABT-494

Upadacitinib

Adalimumab

Vonoprazan

Prochymal®

Dehydroepiandrosterone

CP-690,550

Asimadoline

CNI-1493

Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 24 total trials

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis (ANTHEM-UC)

The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severe...

Active, not recruiting

Colitis, Ulcerative

Drug: Placebo

Drug: JNJ-77242113

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of gus...

Active, not recruiting

Crohn's Disease

Drug: Ustekinumab

Drug: Guselkumab Dose 3

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) (U-ACHIEVE)

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting

Ulcerative Colitis (UC)

Drug: Placebo

Drug: Upadacitinib (ABT-494)